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Assisted partner services for HIV case-finding
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Data from sub-Saharan Africa show that a substantial reservoir of undiagnosed HIV 
infection remains in the area, as well as a large proportion of diagnosed people who are not 
on treatment. According to UNAIDS, 36·7 million people are living with HIV globally, of 
whom 25·6 million (70%) are in sub-Saharan Africa where 12·0 million (47%) are on 
antiretroviral therapy.1 As of 2015, the global gap for the UNAIDS 90-90-90 targets was 
10·9 million people living with HIV who did not know their HIV status.2 To achieve the first 
90 (diagnosis of HIV), countries need to implement innovative and targeted HIV case-
finding approaches.
Delivery of partner services is the process through which a public health system ensures that 
sex and needle-sharing partners of people infected with HIV are notified of their exposure 
and subsequently assessed and engaged in care.3 Partner services fit into a model of case-
finding through screening because the approach is a type of targeted screening in networks 
of infected and exposed people.4 Partner services have not been included in HIV prevention 
programmes in sub-Saharan Africa. Although partner or family testing of individuals 
diagnosed with HIV and disclosure of infection are within the standard of care, health 
facilities often take a passive approach and focus on the immediate family or household, and 
do not routinely follow up patients to ensure that all of their contacts have been tested. 
Common concerns include loss of confidentiality, the threat of intimate partner violence, 
stigma, discrimination, and absence of community and political support.5 Despite these 
barriers, findings from one review6 of partner services in low-income countries showed that 
most people accepted the principles of partner notification.
New evidence further reinforces the acceptability and effectiveness of partner services. In 
The Lancet HIV, Peter Cherutich and colleagues7 test a partner services programme in what 
they describe as a pragmatic community trial. This unmasked cluster-randomised trial done 
in 18 districts in Kenya compared immediate with delayed (6 weeks after enrolment) 
assisted partner services. Compared with the delayed group, investigators found that 
immediate assisted partner services were associated with an increase in partner HIV testing 
(incidence rate ratio 4·8, 95% CI 3·7–6·4), the number of sex partners testing for the first 
time (14·8, 5·4–41·0), new HIV diagnoses (5·0, 3·2–7·9), and enrolment of HIV-positive 
partners into care (4·4, 2·6–7·4).
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This study shows the proper pragmatic use of randomisation in population-level studies 
because the study population was randomised to a new approach in the context of the 
existing programme. Most importantly, this approach to randomisation serves translational 
aspects of research through the fact that the study itself tests the principle of partner services 
in the relevant programmatic setting.8 Even the study participation (70%) would be 
considered meaningful in the context of most prevention programmes for HIV and sexually 
transmitted diseases. Of course, investigators of future studies might learn how to modify 
steps in the partner services algorithm tested in this study to improve efficiency. In the 
meantime, application of the partner services algorithm as tested in this study seems to pose 
little risk because the new approach resulted in an almost 15 times increase in new testing 
and five times increase in new diagnoses. With effect sizes this large, a very large unknown 
confounder would have to be present in the environment for the findings not to be valid. 
Despite achievements to date and known barriers that have prevented adoption of partner 
services, findings from this study support calls to say no to complacency made during the 
AIDS 2016 conference in Durban.9 Scaling up of immediate assisted partner services is 
clearly an innovative casefinding approach that might be instrumental in helping countries 
achieve UNAIDS Fast-Track targets by 2030.10
Some issues pertinent to sustainability exist. For example, the authors note counsellors’ 
training requirements and suggest that some efforts might be needed to rely on “task shifting 
to a less highly educated cadre than those used in this study” in the future. Additionally, 
districts with administrative hurdles or low numbers of people with HIV infections were 
excluded from the trial. A national programme would of course have to overcome these 
hurdles and provide a minimum level of services for low-prevalence sites. That noted, the 
study incorporated 18 of 28 districts across Kenya with a-priori administrative acceptance, 
indicating first steps toward sustainability.
In the USA, HIV partner services appear to be a cost-effective prevention and control 
strategy.11 In countries such as many of those in sub-Saharan Africa, even though the cost of 
treatment might be lower than in the USA, and therefore cost-effectiveness harder to 
achieve, the number of undiagnosed HIV cases in sub-Saharan Africa suggests that any 
method that yields as many cases as shown in this study is likely to be worth the investment. 
For that matter, a partner services programme also reveals networks of transmission and 
social contact and connects people infected with HIV to life-saving health services. A well 
known comment in partner services literature reads “contact tracing’s price is not its 
value”,12 an axiom shown once again.
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